MSN: UC, UC Health launching clinical trial to study effectiveness of COVID-19 vaccine
Vaccine uses a genetic code to produce proteins that may generate protective antibodies
UC and UC Health are hosting a Phase 3 clinical trial to evaluate the effectiveness of a vaccine for COVID-19. UC is one of 90 sites across the United States selected for the study, which will administer the vaccine to volunteer participants and monitor its efficacy in eliciting an immune response that provides protection from COVID-19. The study is led by Carl Fichtenbaum, MD, and Maggie Powers-Fletcher, PhD, both of the UC College of Medicine Division of Infectious Diseases.
Other coverage:
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Stay up on all UC's COVID-19 stories, read more #UCtheGood content, or take a UC virtual visit and begin picturing yourself at an institution that inspires incredible stories.
Related Stories
UC Speech & Hearing Clinic serves patients while acting as training site
September 30, 2026
The University of Cincinnati's Speech & Hearing Clinic provides graduate students in audiology and speech-language pathology with hands-on experience while delivering care to patients across the region. Located on the university's medical campus, the clinic serves patients of all ages and was recently featured on Spectrum News 1 Ohio.
UC economist warns of higher heating costs this winter
September 30, 2026
David Brasington explains why home heating will cost so much this winter and how to save money.
Former mistress of convicted pastor and former American Idol contestant likely won’t face criminal charges
September 30, 2026
Mark Godsey, a criminal law professor in the Donald P. Klekamp College of Law at the University of Cincinnati spoke with NBC News about a criminal case that has attracted national attention.